Dr. James B. Groce

Professor of Pharmacy
Pharmacy Practice
College of Pharmacy & Health Sciences
Office Address:
Maddox Hall
Mailing Address:
205 Day Dorm Rd
Buies Creek, NC 27506

Biography

James B. Groce III, Pharm.D., CACP, is Professor, Department of Pharmacy Practice at Campbell University College of Pharmacy and Health Sciences. He also is Clinical Assistant Professor of Medicine at the University of North Carolina School of Medicine, and Clinical Pharmacy Specialist-Anticoagulation at the Moses H. Cone Memorial Hospital in Greensboro, North Carolina.

Throughout his career in pharmacy, Dr. Groce has been published and cited on important healthcare topics in numerous peer-reviewed medical and pharmacy journals as well as textbooks of pharmacy. He has served as principal investigator on a number of studies, including many that supported the concept of outpatient treatment of venous thromboembolism. His published research has also evaluated the pharmacoeconomics of using low molecular weight heparins for outpatient treatment of deep venous thrombosis (DVT) in a community hospital setting, various heparin weight-based dosing nomograms, and the utility of heparin level determinations and outcomes analysis. He served as site-principle investigator for the DiET study. On December 10, 2016, the US Food and Drug Administration (FDA) cleared STA® – Liatest® D-Di for the exclusion of the diagnosis of deep vein thrombosis (DVT) on data reported from the multi-national, DiET study. Currently he is the principle investigator for an assay evaluating the performance of a chromogenic assay for the measurement of direct oral Factor Xa inhibtors—the results of which are before the FDA being evaluated for clearance as the first FDA approved assay for this purpose. 

Dr. Groce’s colleagues and the public have benefited from his unique expertise. He served as the only Pharmacist upon the Technical Advisory Panel of The Joint Commission/National Quality Forum for creation of core measures for prevention and treatment of venous thromboembolism which culminated in National Hospital Quality Measures for venous thromboembolism October 1, 2009 in the United States. All these activities have earned Dr. Groce national and global recognition for his contributions to this clinical area of interest and research.


Education

  • Doctor of Pharmacy, Campbell University
  • BS Pharmacy, University of North Carolina at Chapel Hill
  • BA Zoology, University of North Carolina at Chapel Hill

Credentials

  • Licentiate in Pharmacy, North Carolina. Certificate No. 008741
  • Certified Anticoagulation Care Provider, The National Certification Board of Anticoagulation Care Providers. Certificate No. 0009-VBC-0599
  • Certified Collaborative Institutional Training Initiative (CITI)

Career Highlights

  • Professor, Department of Pharmacy Practice at Campbell University's College of Pharmacy & Health Sciences
  • Clinical Assistant Professor of Medicine at the University of North Carolina School of Medicine

Awards, Recognition & Honors

  • Appointed: UNC Eshelman School of Pharmacy Alumni Association Board of Directors, effective July 1, 2015 for two-year term
  • Reappointed: Clinical Assistant Professor of Medicine, Department of Medicine, School of Medicine, The University of North Carolina at Chapel Hill. July 1, 2013
  • Appointed: American Society of Health System Pharmacists Expert Panel on Optimizing Antithrombotic Management: An Assessment Tool for Health-System Pharmacy Departments. May 18-19, 2011. ASHP Headquarters, Bethesda, MD
  • Awarded: Dean’s Excellence in Research/Teaching Award by Dean Ronald Maddox, Campbell University College of Pharmacy and Health Sciences. May 2, 2010. Buies Creek, NC
  • Appointed: Thrombosis Advisory Council-Policy Workstream Group for delivery of direction, opinion and recommendations on pertinent issues for (potential) US health care policy changes. Appointed by Co-Chairs: Samuel Z.Goldhaber MD of the Brigham and Wom

Organizations

  • Alpha Chi Sigma Professional Chemistry Fraternity
  • American Association of Colleges of Pharmacy
  • American College of Clinical Pharmacy
  • American Pharmaceutical Association
  • American Society of Health-System Pharmacists
  • North Carolina Association of Pharmacists
  • Rho Chi, Gamma Iota Chapter

Editorial

  • Kim JJ, Hill H, Groce JB III, Granfortuna J, Makhlouf T. Pharmacy student monitoring of direct oral anticoagulants. J Pharm Pract. 2018 Jan 1:897190017752713. doi: 10.1177/0897190017752713. [Epub ahead of print]. J Pharm Pract. 2018 Jan 1:89719001775271
  • Validation of STA-Liatest D-Dimer assay for exclusion of proximal deep vein thrombosis according to the latest CLSI/FDA guideline. Results of a multicenter management study. Submitted to Journal of Blood Coagulation & Fibrinolysis. Pernod G, Groce JB
  • Lee S, Groce JB, Kim J. A pilot process to identify and switch high-risk warfarin patients to direct oral anticoagulants. Journal of Hospital Administration, Vol. 6, No. 5, October 2017, e-Version http://www.sciedupress.com/journal/index.php/jha/issue/vi
  • PB 1135 Validation of STA-Liatest D-Di Assay for Exclusion of Deep Vein Thrombosis According to the Latest Clinical and Laboratory Standard Institute/Food and Drug Administration Guideline. Results of a Multicenter Management Study. C. Aguilar1, M. Sartor
  • Groce JB. Thromboembolic Disease. In: Shargel L, Mutnick AH, Souney PF, Swanson LN. Eds. Comprehensive Pharmacy Review, 8th Edition. Chapter 35 pages 659 – 673. Lippincott Williams & Wilkins Publisher, Philadelphia, PA. January 2013